Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of <scp>PUR3100</scp> , a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double‐blind study in healthy adults